• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测子宫颈癌前病变。筛查性阴道镜检查对细胞学检查的贡献。

Detecting premalignant cervical lesions. Contribution of screening colposcopy to cytology.

作者信息

Davison J M, Marty J J

机构信息

Department of Obstetrics and Gynecology, Truman Medical Center, School of Medicine, University of Missouri-Kansas City 64108.

出版信息

J Reprod Med. 1994 May;39(5):388-92.

PMID:8064706
Abstract

The combination of parallel cytology and screening colposcopy was found to increase the detection of premalignant cervical lesions from 8.2% in a group of patients (based on cytology alone) to 15.3% in that group (based on the combination). The combination of the two methods used in parallel increased the sensitivity, negative predictive value and efficiency of cervical cancer screening over cytology alone while having only a small negative impact on the positive predictive value of a positive test. The addition of screening colposcopy to cytology produces a significant improvement over current uniphasic screening protocols.

摘要

研究发现,并行细胞学检查与筛查性阴道镜检查相结合,可将一组患者中癌前宫颈病变的检出率从(仅基于细胞学检查时的)8.2%提高至该组(基于联合检查时的)15.3%。并行使用这两种方法,相较于单独使用细胞学检查,提高了宫颈癌筛查的敏感性、阴性预测值和效率,同时对阳性检查结果的阳性预测值仅有较小的负面影响。在细胞学检查基础上增加筛查性阴道镜检查,相较于目前的单相筛查方案有显著改善。

相似文献

1
Detecting premalignant cervical lesions. Contribution of screening colposcopy to cytology.检测子宫颈癌前病变。筛查性阴道镜检查对细胞学检查的贡献。
J Reprod Med. 1994 May;39(5):388-92.
2
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].[卫生技术评估报告:基于人乳头瘤病毒DNA的宫颈癌前病变初筛]
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
3
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.25 岁及以上女性宫颈癌筛查中致癌型人乳头瘤病毒(HPV)检测及 HPV16 或 HPV18 基因分型的性能:ATHENA 研究的一项亚组分析。
Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.
4
Screening of cervical neoplasia in HIV-infected women in India.印度 HIV 感染女性的宫颈癌筛查。
AIDS. 2013 Feb 20;27(4):607-15. doi: 10.1097/QAD.0b013e32835b1041.
5
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.人乳头瘤病毒(HPV)DNA检测联合细胞学分流和/或重复HPV DNA检测在原发性宫颈癌筛查中的效能
J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.
6
The role of early colposcopy in the management of females with first episode anogenital warts.
Int J STD AIDS. 1994 Sep-Oct;5(5):343-5. doi: 10.1177/095646249400500511.
7
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.人乳头瘤病毒检测与液基细胞学检查:宫颈癌随机对照试验新技术招募时的结果
J Natl Cancer Inst. 2006 Jun 7;98(11):765-74. doi: 10.1093/jnci/djj209.
8
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.在随机环境中对原发性人乳头瘤病毒筛查与传统细胞学进行特定年龄评估。
J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.
9
[Real-world research on cervical cancer screening program and effect evaluation for Chinese population].[中国人群宫颈癌筛查项目的真实世界研究及效果评估]
Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):764-771. doi: 10.3760/cma.j.issn.0253-3766.2018.10.008.
10
Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.从细胞学筛查向基于人乳头瘤病毒检测的宫颈癌筛查转变:阴道镜检查的意义。
Int J Cancer. 2012 Apr 15;130(8):1879-87. doi: 10.1002/ijc.26194. Epub 2011 Aug 2.